― 25 ―radiopharmaceutical [18F] FPEB, Nat. Protoc., 14, 1530 -1545 (2019).3. Matsuoka K, Obata H, Nagatsu K, Kojima M, Yoshino T, Ogawa M, Matsunaga, S: Transition-metal-free nucleophilic 211At-astatination of spirocyclic aryliodonium ylides, Org. Biomol. Chem., 19, 5525-5528 (2021).4. Ohshima Y, Sudo H, Watanabe S, Nagatsu K, Tsuji AB, Sakashita T, Ito YM, Yoshinaga K, Higashi T, Ishioka NS: Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model, Eur. J. Nuc. Med. Mol. Imag., 45, 999-1010 (2018).
元のページ ../index.html#27